Shares of Scancell Holdings Plc (LON:SCLP) reached a new 52-week low on Friday . The stock traded as low as GBX 5.41 ($0.07) and last traded at GBX 5.60 ($0.07), with a volume of 570581 shares traded. The stock had previously closed at GBX 5.90 ($0.08).
The stock has a market capitalization of $21.72 million and a price-to-earnings ratio of -3.73.
COPYRIGHT VIOLATION WARNING: This story was originally reported by Ticker Report and is owned by of Ticker Report. If you are viewing this story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this story can be viewed at https://www.tickerreport.com/banking-finance/4223799/scancell-sclp-hits-new-12-month-low-at-5-41.html.
Scancell Holdings plc engages in the discovery and development of novel monoclonal antibodies and vaccines for the treatment of cancer in the United Kingdom. The company's products include SCIB1, a plasmid DNA vaccine, which is in Phase I/II clinical trials for the treatment of melanoma; SCIB2 to treat lung cancer antigen; and Modi-1, which is in the pre-clinical development to treat triple negative breast cancer, ovarian cancer, and sarcoma.
Featured Article: How to trade on quiet period expirations
Receive News & Ratings for Scancell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scancell and related companies with MarketBeat.com's FREE daily email newsletter.